Antitumor activity of a novel oral signal transducer and activator of transcription 3 inhibitor YHO-1701.

Saved in:
Bibliographic Details
Title: Antitumor activity of a novel oral signal transducer and activator of transcription 3 inhibitor YHO-1701.
Authors: Nishisaka F; Center for Drug Discovery, Graduate School of Pharmaceutical Sciences, University of Shizuoka, Shizuoka, Japan.; Yakult Central Institute, Yakult Honsha Co., Ltd., Kunitachi, Tokyo, Japan., Taniguchi K; Yakult Central Institute, Yakult Honsha Co., Ltd., Kunitachi, Tokyo, Japan., Tsugane M; Yakult Central Institute, Yakult Honsha Co., Ltd., Kunitachi, Tokyo, Japan., Hirata G; Yakult Central Institute, Yakult Honsha Co., Ltd., Kunitachi, Tokyo, Japan., Takagi A; Yakult Central Institute, Yakult Honsha Co., Ltd., Kunitachi, Tokyo, Japan., Asakawa N; Yakult Central Institute, Yakult Honsha Co., Ltd., Kunitachi, Tokyo, Japan., Kurita A; Yakult Central Institute, Yakult Honsha Co., Ltd., Kunitachi, Tokyo, Japan., Takahashi H; Pharmaceutical Department, Yakult Honsha Co., Ltd., Tokyo, Japan., Ogo N; Center for Drug Discovery, Graduate School of Pharmaceutical Sciences, University of Shizuoka, Shizuoka, Japan., Shishido Y; Yakult Central Institute, Yakult Honsha Co., Ltd., Kunitachi, Tokyo, Japan., Asai A; Center for Drug Discovery, Graduate School of Pharmaceutical Sciences, University of Shizuoka, Shizuoka, Japan.
Source: Cancer science [Cancer Sci] 2020 May; Vol. 111 (5), pp. 1774-1784. Date of Electronic Publication: 2020 Mar 24.
Publication Type: Journal Article
Journal Info: Publisher: Wiley Publishing on behalf of the Japanese Cancer Association Country of Publication: England NLM ID: 101168776 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1349-7006 (Electronic) Linking ISSN: 13479032 NLM ISO Abbreviation: Cancer Sci Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Be the first to leave a comment!
You must be logged in first